Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Allergy ; 78(8): 2327-2328, 2023 08.
Article in English | MEDLINE | ID: mdl-37310075
2.
Front Psychiatry ; 11: 564, 2020.
Article in English | MEDLINE | ID: mdl-32670106

ABSTRACT

Movement, behavioral, and neuropsychiatric disorders in children have been linked to infections and a group of anti-neuronal autoantibodies, implying dopamine receptor-mediated encephalitis within the basal ganglia. The purpose of this study was to determine if anti-neuronal biomarkers, when used as a group, confirmed the acute disease in Sydenham chorea (SC) and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS). IgG autoantibodies against four neuronal autoantigens (tubulin, lysoganglioside GM1, and dopamine receptors D1 and D2) were detected in SC sera (N=8), sera and/or cerebrospinal fluid (CSF) from two groups of PANDAS cases (N=25 first group and N=35 second group), sera from Tourette's syndrome (N=18), obsessive-compulsive disorder (N=25), attention deficit hyperactivity disorder (N=18), and healthy controls (N=28) by direct enzyme-linked immunosorbent assay (ELISA). IgG specific for neuronal autoantigens was significantly elevated during the acute symptomatic phase, and the activity of calcium/calmodulin-dependent protein kinase II (CaMKII) pathway was significantly elevated in human neuronal cells. Five assays confirmed the disease in SC and in two groups of children with PANDAS. In 35 acute onset PANDAS patients, 32 sera (91.4%) were positive for one or more of the anti-neuronal autoantibodies compared with 9 of 28 healthy controls (32.1%, p<0.0001). Importantly, CSF of 32 (91.4%) PANDAS patients had one or more detectable anti-neuronal autoantibody titers and CaMKII activation. Among healthy control subjects with elevated serum autoantibody titers for individual antigens, none (0%) were positively associated with elevated positive CaMKII activation, which was a striking contrast to the sera of PANDAS subjects, who had 76-89% positive association with elevated individual autoantibody titers and positive CaMKII activity. At 6 months follow-up, symptoms improved for more than 80% of PANDAS subjects, and serum autoantibody titers also significantly decreased. Results reported herein and previously published studies in our laboratory suggest the antibody biomarkers may be a useful adjunct to clinical diagnosis of SC, PANDAS, and related disorders and are the first known group of autoantibodies detecting dopamine receptor-mediated encephalitis in children.

3.
Neuron ; 103(6): 1056-1072.e6, 2019 09 25.
Article in English | MEDLINE | ID: mdl-31324539

ABSTRACT

Motor and cognitive functions depend on the coordinated interactions between dopamine (DA) and acetylcholine (ACh) at striatal synapses. Increased ACh availability was assumed to accompany DA deficiency based on the outcome of pharmacological treatments and measurements in animals that were critically depleted of DA. Using Slc6a3DTR/+ diphtheria-toxin-sensitive mice, we demonstrate that a progressive and L-dopa-responsive DA deficiency reduces ACh availability and the transcription of hyperpolarization-activated cation (HCN) channels that encode the spike timing of ACh-releasing tonically active striatal interneurons (ChIs). Although the production and release of ACh and DA are reduced, the preponderance of ACh over DA contributes to the motor deficit. The increase in striatal ACh relative to DA is heightened via D1-type DA receptors that activate ChIs in response to DA release from residual axons. These results suggest that stabilizing the expression of HCN channels may improve ACh-DA reciprocity and motor function in Parkinson's disease (PD). VIDEO ABSTRACT.


Subject(s)
Acetylcholine/metabolism , Cholinergic Neurons/metabolism , Dopamine/deficiency , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/genetics , Interneurons/metabolism , Neostriatum/metabolism , Parkinson Disease/metabolism , Amphetamine/pharmacology , Animals , Cholinergic Neurons/drug effects , Cholinergic Neurons/physiology , Cyclic AMP-Dependent Protein Kinases/metabolism , Disease Models, Animal , Dopamine/metabolism , Dopamine Agents/pharmacology , Dopamine Plasma Membrane Transport Proteins/genetics , Interneurons/drug effects , Interneurons/physiology , Mice , Neostriatum/cytology , Neostriatum/drug effects , Neostriatum/physiopathology , Parkinson Disease/physiopathology , Patch-Clamp Techniques , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism , Transcription, Genetic
4.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 39(3): 195-200, July-Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-899361

ABSTRACT

Objective: To investigate plasma concentrations of S100B (a calcium-binding protein derived primarily from the glia) and inflammatory cytokines in children with autism and the relationship between S100B and cytokine concentrations. Methods: Plasma levels of S100B, tumor necrosis factor alpha (TNF-α), interferon gamma, interleukin (IL)-1β, IL-4, IL-6, IL-10, and IL-17A were measured in 40 unmedicated children with autism and 35 normally developing healthy children. The severity of autism was assessed using the Childhood Autism Rating Scale (CARS). Results: Concentrations of both S100B and TNF-α were higher in children with autism before and after adjusting for a priori-selected confounders (age, sex, and body mass index). S100B concentrations were higher in children with severe autism compared to children with mild-moderate autism. However, this association remained as a trend after adjusting for confounders. S100B concentrations correlated positively with TNF-α concentrations. Conclusion: Our findings showing an increase in peripheral concentrations of S100B and TNF-α provide limited support to the hypothesis about the roles of altered immune function and S100B in autism spectrum disorder (ASD). Studies of larger numbers of well-characterized individuals with ASD are needed to clarify the potential role of the immune system in the pathophysiology of this disorder.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Tumor Necrosis Factor-alpha/blood , S100 Calcium Binding Protein beta Subunit/blood , Autism Spectrum Disorder/blood , Severity of Illness Index , Biomarkers/blood , Body Mass Index , Cross-Sectional Studies , Interleukins/blood
5.
Braz J Psychiatry ; 39(3): 195-200, 2017.
Article in English | MEDLINE | ID: mdl-28099628

ABSTRACT

OBJECTIVE:: To investigate plasma concentrations of S100B (a calcium-binding protein derived primarily from the glia) and inflammatory cytokines in children with autism and the relationship between S100B and cytokine concentrations. METHODS:: Plasma levels of S100B, tumor necrosis factor alpha (TNF-α), interferon gamma, interleukin (IL)-1ß, IL-4, IL-6, IL-10, and IL-17A were measured in 40 unmedicated children with autism and 35 normally developing healthy children. The severity of autism was assessed using the Childhood Autism Rating Scale (CARS). RESULTS:: Concentrations of both S100B and TNF-α were higher in children with autism before and after adjusting for a priori-selected confounders (age, sex, and body mass index). S100B concentrations were higher in children with severe autism compared to children with mild-moderate autism. However, this association remained as a trend after adjusting for confounders. S100B concentrations correlated positively with TNF-α concentrations. CONCLUSION:: Our findings showing an increase in peripheral concentrations of S100B and TNF-α provide limited support to the hypothesis about the roles of altered immune function and S100B in autism spectrum disorder (ASD). Studies of larger numbers of well-characterized individuals with ASD are needed to clarify the potential role of the immune system in the pathophysiology of this disorder.


Subject(s)
Autism Spectrum Disorder/blood , S100 Calcium Binding Protein beta Subunit/blood , Tumor Necrosis Factor-alpha/blood , Biomarkers/blood , Body Mass Index , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Interleukins/blood , Male , Severity of Illness Index
6.
PLoS One ; 10(3): e0120499, 2015.
Article in English | MEDLINE | ID: mdl-25793715

ABSTRACT

Several autoantibodies (anti-dopamine 1 (D1R) and 2 (D2R) receptors, anti-tubulin, anti-lysoganglioside-GM1) and antibody-mediated activation of calcium calmodulin dependent protein kinase II (CaMKII) signaling activity are elevated in children with Sydenham's chorea (SC). Recognizing proposed clinical and autoimmune similarities between SC and PANDAS (pediatric autoimmune neuropsychiatric disorder associated with a streptococcal infection), we sought to identify serial biomarker changes in a slightly different population. Antineuronal antibodies were measured in eight children (mean 11.3 years) with chronic, dramatic, recurrent tics and obsessive-compulsive disorder (OCD) associated with a group A ß-hemolytic streptococcal (GABHS) respiratory tract infection, but differing because they lacked choreiform movements. Longitudinal serum samples in most subjects included two pre-exacerbation samples, Exac), one midst Exac (abrupt recurrence of tic/OCD; temporally association with a GABHS infection in six of eight subjects), and two post-Exac. Controls included four groups of unaffected children (n = 70; mean 10.8 years) obtained at four different institutions and published controls. Clinical exacerbations were not associated with a significant rise in antineuronal antibody titers. CaMKII activation was increased at the GABHS exacerbation point in 5/6 subjects, exceeded combined and published control's 95th percentile at least once in 7/8 subjects, and median values were elevated at each time point. Anti-tubulin and anti-D2R titers did not differ from published or combined control group's 95th percentile or median values. Differences in anti-lysoganglioside-GM1 and anti-D1R titers were dependent on the selected control. Variances in antibody titers and CaMKII activation were identified among the institutional control groups. Based on comparisons to published studies, results identify two groups of PANDAS: 1) a cohort, represented by this study, which lacks choreiform movements and elevated antibodies against D2R; 2) the originally reported group with choreiform movements and elevated anti-D2R antibodies, similar to SC. Increased antibody mediated CaMKII activation was found in both groups and requires further study as a potential biomarker.


Subject(s)
Antibodies/metabolism , Chorea/diagnosis , Disease Progression , Neurons/metabolism , Obsessive-Compulsive Disorder/etiology , Streptococcal Infections/complications , Tics/etiology , Adolescent , Antistreptolysin/metabolism , Autoantibodies/metabolism , Biomarkers/blood , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Case-Control Studies , Child , Chorea/blood , Chorea/immunology , Chronic Disease , Deoxyribonucleases/metabolism , Female , Humans , Immunoglobulin G/metabolism , Longitudinal Studies , Male , Recurrence
7.
Brain Res ; 1617: 63-71, 2015 Aug 18.
Article in English | MEDLINE | ID: mdl-25304360

ABSTRACT

A newly discovered cell-to-cell communication system involves small, membrane-enveloped nanovesicles, called exosomes. We describe here how these extracellular nanoparticles were discovered and how it became gradually apparent that they play fundamental roles in regulation of physiological functions and pathological processes. Exosomes enable intercellular communication by transporting genetic material, proteins and lipids to cells in their vicinity or at distant sites, and subsequently regulating functions of targeted cells. Relatively recent experiments indicate that exosomes are released also by CNS cells, including cortical and hippocampal neurons, glial cells, astrocytes and oligodendrocytes, and that exosomes have significant impact on pathophysiology of the brain. How it is decided what individual exosomes will carry to their targets is not understood, but it appears that the contents may represent "signature cargos" that are characteristic for various conditions. Exploration of such characteristics could result in discovery of novel diagnostic biomarkers. Exosomes are also promising as a vehicle for therapeutic delivery of micro RNA or other compounds. How to deliver exosomes to selected sites has been a tantalizing question. Recent experiments revealed that at least some exosomes carry antibodies on their surface, suggesting that it may be feasible to deliver exosomes to unique sites based on the recognition of antigens by those antibodies. This discovery implies that rather precise targeting of both natural and engineered exosomes may be feasible. This would reduce distribution volume of therapeutics, and consequently minimize their side effects. This article is part of a Special Issue entitled Neuroimmunology in Health And Disease.


Subject(s)
Brain/physiology , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/therapy , Exosomes/physiology , Animals , Biomarkers , Brain/immunology , Brain/physiopathology , Cell Communication , Central Nervous System Diseases/immunology , Drug Carriers/therapeutic use , Exosomes/immunology , Humans
8.
Apoptosis ; 18(6): 702-12, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23494481

ABSTRACT

Mitochondrial glutathione pool is vital in protecting cells against oxidative stress as the majority of the cellular reactive oxygen species are generated in mitochondria. Oxidative stress is implicated as a causative factor in neuronal death in neurodegenerative disorders. We hypothesized that depletion of mitochondrial glutathione leads to mitochondrial dysfunction and apoptotic death of SK-N-SH (human neuroblastoma) cells and investigated the neuroprotective strategies against GSH depletion. SK-N-SH cells were treated with two distinct inhibitors of glutathione metabolism: L-buthionine-(S, R)-sulfoximine (BSO) and ethacrynic acid (EA). EA treatment caused depletion of both the total and mitochondrial glutathione (while BSO had no effect on mitochondrial glutathione), enhanced rotenone-induced ROS production, and reduced the viability of SK-N-SH cells. Glutathione depletion by BSO or EA demonstrated positive features of mitochondria-mediated apoptosis in neuroblastoma cell death. Prevention of apoptosis by Bcl2 overexpression or use of antioxidant ebselen did not confer neuroprotection. Co-culture with U-87 (human glioblastoma) cells protected SK-N-SH cells from the cell death. Our data suggest that depletion of mitochondrial glutathione leads to mitochondrial dysfunction and apoptosis. The study indicates that preventing mitochondrial glutathione depletion could become a novel strategy for the development of neuroprotective therapeutics in neurodegenerative disorders.


Subject(s)
Apoptosis/drug effects , Glutathione/metabolism , Mitochondria/drug effects , Neurons/physiology , Apoptosis/physiology , Azoles/pharmacology , Buthionine Sulfoximine/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Coculture Techniques , Cytochromes c/metabolism , Cytosol/metabolism , Ethacrynic Acid/pharmacology , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Isoindoles , Mitochondria/metabolism , Neuroblastoma/metabolism , Neuroblastoma/pathology , Organoselenium Compounds/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism , bcl-2-Associated X Protein/metabolism
9.
J Child Adolesc Psychopharmacol ; 21(6): 555-64, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22070180

ABSTRACT

Risperidone has been shown to improve serious behavioral problems in children with autism. Here we asked whether risperidone-associated improvement was related to changes in concentrations of inflammatory molecules in the serum of these subjects. Seven molecules were identified as worthy of further assessment by performing a pilot analysis of 31 inflammatory markers in 21 medication-free subjects with autism versus 15 healthy controls: epidermal growth factor (EGF), interferon-γ (IFN-γ), interleukin (IL)-13, IL-17, monocyte chemoattractant protein-1 (MCP-1), IL-1 and IL-1-receptor antagonist. Serum concentrations of these markers were then established in a different set of subjects that participated in a double-blind, clinical trial and an expanded group of healthy subjects. In the first analysis, samples obtained from subjects with autism at baseline visits were compared to visits after 8-week treatment with placebo (n=37) or risperidone (n=40). The cytokine concentrations remained stable over the 8-week period for both risperidone and placebo groups. In the second analysis, we explored further the differences between medication-free subjects with autism (n=77) and healthy controls (recruited independently; n=19). Serum levels of EGF were elevated in subjects with autism (median=103 pg/mL, n=75) in comparison to healthy controls (75 pg/mL, n=19; p<0.05), and levels of IL-13 were decreased in autism (median=0.8 pg/mL, n=77) in comparison to controls (9.8 pg/mL, n=19; p=0.0003). These changes did not correlate with standardized measures used for a diagnosis of autism. In summary, risperidone-induced clinical improvement in subjects with autism was not associated with changes in the serum inflammatory markers measured. Whether altered levels of EGF and IL-13 play a role in the pathogenesis or phenotype of autism requires further investigation.


Subject(s)
Autistic Disorder/drug therapy , Epidermal Growth Factor/drug effects , Irritable Mood/drug effects , Risperidone/pharmacology , Risperidone/therapeutic use , Adolescent , Anti-Inflammatory Agents/pharmacology , Antipsychotic Agents/pharmacology , Antipsychotic Agents/therapeutic use , Autistic Disorder/blood , Autistic Disorder/psychology , Biomarkers/blood , Child , Child, Preschool , Double-Blind Method , Epidermal Growth Factor/blood , Female , Humans , Inflammation Mediators/blood , Interleukin-13/blood , Irritable Mood/physiology , Male
10.
Circulation ; 124(2): 196-205, 2011 Jul 12.
Article in English | MEDLINE | ID: mdl-21690493

ABSTRACT

BACKGROUND: Ligands activating the transcription factor peroxisome proliferator-activated receptor-γ (PPARγ) have antiinflammatory effects. Vascular rejection induced by allogeneic T cells can be responsible for acute and chronic graft loss. Studies in rodents suggest that PPARγ agonists may inhibit graft vascular rejection, but human T-cell responses to allogeneic vascular cells differ from those in rodents, and the effects of PPARγ in human transplantation are unknown. METHODS AND RESULTS: We tested the effects of PPARγ agonists on human vascular graft rejection using a model in which human artery is interposed into the abdominal aorta of immunodeficient mice, followed by adoptive transfer of allogeneic (to the artery donor) human peripheral blood mononuclear cells. Interferon-γ-dependent rejection ensues within 4 weeks, characterized by intimal thickening, T-cell infiltrates, and vascular cell activation, a response resembling clinical intimal arteritis. The PPARγ agonists 15-deoxy-prostaglandin-J(2), ciglitazone, and pioglitazone reduced intimal expansion, intimal infiltration of CD45RO(+) memory T cells, and plasma levels of inflammatory cytokines. The PPARγ antagonist GW9662 reversed the protective effects of PPARγ agonists, confirming the involvement of PPARγ-mediated pathways. In vitro, pioglitazone inhibited both alloantigen-induced proliferation and superantigen-induced transendothelial migration of memory T cells, indicating the potential mechanisms of PPARγ effects. CONCLUSION: Our results suggest that PPARγ agonists inhibit allogeneic human memory T cell responses and may be useful for the treatment of vascular graft rejection.


Subject(s)
Arteries/immunology , Arteries/transplantation , Graft Rejection/immunology , Hypoglycemic Agents/pharmacology , PPAR gamma/agonists , Prostaglandin D2/analogs & derivatives , T-Lymphocytes/immunology , Thiazolidinediones/pharmacology , Adoptive Transfer , Anilides/pharmacology , Animals , Arteries/pathology , Cell Movement/drug effects , Cell Movement/immunology , Cell Proliferation/drug effects , Cytokines/immunology , Graft Rejection/drug therapy , Graft Rejection/pathology , Humans , Immunologic Memory/drug effects , Immunologic Memory/immunology , Isoantigens/immunology , Mice , Mice, SCID , PPAR gamma/antagonists & inhibitors , PPAR gamma/immunology , Pioglitazone , Prostaglandin D2/pharmacology , Superantigens/pharmacology , T-Lymphocytes/pathology , T-Lymphocytes/transplantation , Transplantation, Heterologous , Transplantation, Homologous
11.
J Am Acad Child Adolesc Psychiatry ; 50(2): 108-118.e3, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21241948

ABSTRACT

OBJECTIVE: The objective of this blinded, prospective, longitudinal study was to determine whether new group A ß hemolytic streptococcal (GABHS) infections are temporally associated with exacerbations of tic or obsessive-compulsive (OC) symptoms in children who met published criteria for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). A group of children with Tourette syndrome and/or OC disorder without a PANDAS history served as the comparison (non-PANDAS) group. METHOD: Consecutive clinical ratings of tic and OC symptom severity were obtained for 31 PANDAS subjects and 53 non-PANDAS subjects. Clinical symptoms and laboratory values (throat cultures and streptococcal antibody titers) were evaluated at regular intervals during a 25-month period. Additional testing occurred at the time of any tic or OC symptom exacerbation. New GABHS infections were established by throat swab cultures and/or recent significant rise in streptococcal antibodies. Laboratory personnel were blinded to case or control status, clinical (exacerbation or not) condition, and clinical evaluators were blinded to the laboratory results. RESULTS: No group differences were observed in the number of clinical exacerbations or the number of newly diagnosed GABHS infections. On only six occasions of a total of 51 (12%), a newly diagnosed GABHS infection was followed, within 2 months, by an exacerbation of tic and/or OC symptoms. In every instance, this association occurred in the non-PANDAS group. CONCLUSIONS: This study provides no evidence for a temporal association between GABHS infections and tic/OC symptom exacerbations in children who meet the published PANDAS diagnostic criteria.


Subject(s)
Obsessive-Compulsive Disorder/microbiology , Respiratory Tract Infections/complications , Streptococcal Infections/complications , Streptococcus pyogenes , Tourette Syndrome/microbiology , Adolescent , Case-Control Studies , Child , Double-Blind Method , Female , Humans , Male , Prospective Studies , Severity of Illness Index , United States
12.
Brain Behav Immun ; 25(3): 532-8, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21156204

ABSTRACT

BACKGROUND: Post-infectious autoimmunity and immune deficiency have been implicated in the pathogenesis of Tourette syndrome (TS). We asked here whether B cell immunity of patients with TS differs from healthy subjects. METHODS: In two independent cross-sectional samples, we compared serum levels of IgG1, IgG2, IgG3, IgG4, IgM, IgA, and IgE in 21 patients with TS from Yale University (17 males, 4 females, 8-16 years) versus 21 healthy controls (13 males, 8 females, 7-17 years); and in 53 patients with TS from Groningen University (45 males, 8 females, 6-18 years) versus 53 healthy controls (22 males, 31 females, 6-18 years), respectively. We also investigated correlations between Ig concentrations and symptom severity. In 13 additional patients (9 males, 4 females, age range 9-14), we established Ig profiles at time points before, during, and after symptom exacerbations. RESULTS: IgG3 levels were significantly lower in Yale patients compared to healthy children (medians 0.28 versus 0.49 mg/ml, p=.04), while levels of IgG2, IgG4, and IgM in patients were lower at trend-level significance (p≤.10). Decreased IgG3 (medians 0.45 versus 0.52 mg/ml; p=.05) and IgM (medians 0.30 versus 0.38 mg/ml; p=.04) levels were replicated in the Groningen patients. Ig levels did not correlate with symptom severity. There was a trend-level elevation of IgG1 during symptom exacerbations (p=.09). CONCLUSION: These pilot data indicate that at least some patients with TS have decreased serum IgG3, and possibly also IgM levels, though only few subjects had fully expressed Ig immunodeficiency. Whether these changes are related to TS pathogenesis needs to be investigated.


Subject(s)
Immunoglobulins/blood , Tourette Syndrome/blood , Adolescent , Analysis of Variance , Child , Cross-Sectional Studies , Female , Humans , Immunoglobulins/immunology , Male , Pilot Projects , Severity of Illness Index , Statistics, Nonparametric , Tourette Syndrome/immunology
13.
Brain Behav Immun ; 24(7): 1069-73, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20193755

ABSTRACT

BACKGROUND: Post-infectious autoimmunity has been implicated in pathogenesis of Tourette's syndrome (TS) but no evidence of inflammation in central nervous system has been reported yet. We evaluated the expression of genes encoding selected inflammatory factors in post-mortem specimen of adult TS patients: interferon-γ (a cytokine released from CD8 and Thelper 1 CD4 subset of T lymphocytes), interleukin-2 (IL-2, a growth factor derived from T lymphocytes), interleukin-1 ß (a cytokine involved in initiation of inflammation), monocyte chemotactic factor -1 (MCP-1, a marker of chronic inflammation) and CD45 (pan-leukocytic marker). For validation purposes, we determined expression of three genes that were previously reported to be elevated in post-mortem specimen of other TS cases: protein tyrosine phosphatase receptor-N (PTPR-N), PTPR-U and recoverin. METHODS: Total RNA was isolated from formalin fixed brain tissue sections of basal ganglia area from four patients with TS and four control subjects, and real-time reverse transcription-polymerase chain reaction analysis was employed to quantitatively evaluate gene expression of the selected genes. RESULTS: Significantly increased expression of MCP-1, IL-2 and PTPR-N was observed in TS cases (6.5-fold, 2.3-fold and 16.1-fold increase, respectively, p<0.05). CONCLUSIONS: Elevated expression of MCP-1 and IL-2 supports the possibility of chronic inflammatory processes in the basal ganglia. Replication of elevated expression of PTPR-N in TS specimen suggests that pathway(s) involving this molecule may be important in TS pathogenesis.


Subject(s)
Basal Ganglia/immunology , Chemokine CCL2/immunology , Interleukin-2/immunology , Receptor-Like Protein Tyrosine Phosphatases, Class 8/immunology , Tourette Syndrome/immunology , Adult , Aged , Autopsy , Basal Ganglia/metabolism , Chemokine CCL2/genetics , Female , Humans , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-2/genetics , Leukocyte Common Antigens/genetics , Leukocyte Common Antigens/immunology , Male , Middle Aged , Polymerase Chain Reaction , RNA , Receptor-Like Protein Tyrosine Phosphatases, Class 2/genetics , Receptor-Like Protein Tyrosine Phosphatases, Class 2/immunology , Receptor-Like Protein Tyrosine Phosphatases, Class 8/genetics , Recoverin/genetics , Recoverin/immunology , Tourette Syndrome/genetics
14.
Biol Psychiatry ; 67(7): 679-83, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-20006327

ABSTRACT

BACKGROUND: Postinfectious autoimmunity has been implicated in Tourette's syndrome and obsessive-compulsive disorder (TS/OCD), whereas increased frequency of upper respiratory tract infections (URTI) in TS/OCD patients suggests immune deficiency. We hypothesized that antineuronal antibodies may be elevated in patients (reflecting autoimmune processes), and levels of total immunoglobulins (Igs) may be decreased (reflecting immune deficiency). METHODS: We analyzed plasma of TS/OCD patients (n = 24) and healthy age- and sex-matched control subjects (n = 22) by enzyme-linked immunosorbent assay (ELISA) for the levels of total and specific IgG, IgM, and IgA against antigens previously identified in multiple sclerosis (myelin basic protein and myelin-associated glycoprotein) and Sydenham's chorea (ganglioside-GM1, lysoganglioside, and tubulin). RESULTS: Total IgA was decreased in TS/OCD patients (median 115 mg/100 mL) compared with control subjects (141 mg/100 mL; p = .02). Specific IgA against all antigens, except tubulin were also decreased in the patients (MPB 0 vs. 13 [ELISA units [EU]; myelin-associated glycoprotein 29 vs. 44 EU, p = .04; ganglioside GM1 21 vs. 35 EU, p = .01; lysoganglioside 44 vs. 56 EU, p = .03; tubulin 44 vs. 44 EU, p = .8). The levels of total IgA and anti-myelin basic protein (MBP) IgA were significantly lower in the subgroup of pediatric autoimmune neuropsychiatric disorder associated with Streptococcus (PANDAS) cases (n = 10) than in non-PANDAS cases (n = 9; total IgA 98 mg/100 mL vs. 133 mg/mL, p = .03; anti-MBP IgA 1 vs. 6 EU, p = .03) or healthy control subjects (total IgA 141 mg/100 mL, p = .02; anti-MBP IgA 13 EU, p = .005). CONCLUSIONS: At least some TS/OCD patients may suffer IgA dysgammaglobulinemia, possibly rendering the children more prone to URTI.


Subject(s)
Dysgammaglobulinemia , Immunoglobulin A/immunology , Tourette Syndrome , Child , Dysgammaglobulinemia/epidemiology , Dysgammaglobulinemia/immunology , Dysgammaglobulinemia/physiopathology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Male , Tourette Syndrome/epidemiology , Tourette Syndrome/immunology , Tourette Syndrome/physiopathology
15.
Hum Immunol ; 70(10): 790-802, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19524633

ABSTRACT

Immunodeficient mice bearing components of a human immune system present a novel approach for studying human immune responses. We investigated the number, phenotype, developmental kinetics, and function of developing human immune cells following transfer of CD34(+) hematopoietic stem cell (HSC) preparations originating from second trimester human fetal liver (HFL), umbilical cord blood (UCB), or granulocyte colony-stimulating factor-mobilized adult blood (G-CSF-AB) delivered via intrahepatic injection into sublethally irradiated neonatal NOD-scid/gammac(-/-), Balb/c-Rag1(-/-)gammac(-/-), and C.B-17-scid/bg mice. HFL and UCB HSC provided the greatest number and breadth of developing cells. NOD-scid/gammac(-/-) and Balb/c-Rag1(-/-)gammac(-/-) harbored human B and dendritic cells as well as human platelets in peripheral blood, whereas NOD-scid/gammac(-/-) mice harbored higher levels of human T cells. NOD-scid/gammac(-/-) mice engrafted with HFL CD34(+) HSC demonstrated human immunological competence evidenced by white pulp expansion and increases in total human immunoglobulin following immunization with T-dependent antigens and delayed-type hypersensitivity-infiltrating leukocytes in response to antigenic challenge. In conclusion, we describe an encouraging base system for studying human hematopoietic lineage development and function utilizing human HFL or UCB HSC-engrafted NOD-scid/gammac(-/-) mice that is well suited for future studies toward the development of a fully competent humanized mouse model.


Subject(s)
Fetal Blood/immunology , Hematopoietic Stem Cells/immunology , Liver/immunology , Lymphocyte Subsets/immunology , Animals , Granulocyte Colony-Stimulating Factor/immunology , Granulocyte Colony-Stimulating Factor/metabolism , Hematopoietic Stem Cell Mobilization , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/metabolism , Hemocyanins/immunology , Humans , Hypersensitivity, Delayed/immunology , Hypersensitivity, Delayed/pathology , Immunoglobulins/blood , Influenza A Virus, H5N1 Subtype/immunology , Liver/embryology , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymphocyte Subsets/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Radiation Dosage , Spleen/cytology , Spleen/immunology , Thymus Gland/cytology , Thymus Gland/immunology , Whole-Body Irradiation
16.
Biol Psychiatry ; 61(3): 273-8, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-16996487

ABSTRACT

BACKGROUND: Post-streptococcal autoimmune inflammation of basal ganglia was suggested to be an etiological factor in some cases of Tourette syndrome (TS). Since regulatory T (T reg) cells play a major role in preventing autoimmunity, we hypothesized that a defect in T reg cells may be present in children with TS. We also postulated that group A beta hemolytic streptococcal infections could promote autoimmune responses by releasing exotoxins (streptococcal pyrogenic exotoxins [SPE]). METHODS: We analyzed peripheral blood of TS patients and healthy age-matched control subjects by fluorescence-activated cell sorting (FACS) on multiple occasions and determined the numbers of CD4(+)CD25(+)CD69(-) T reg cells. Further, we quantified the number of CD4(+) and CD8(+) lymphocytes with regard to Vbeta chains to which SPEs are known to bind. RESULTS: A significant decrease in T reg cells was observed in patients with moderate to severe TS symptoms compared with healthy age-matched control children. A decrease in T reg cell number was also noted during symptom exacerbations in five out of six patients. Further, we found a significant decrease in numbers of CD8(+)Vbeta18(+) T cells in moderate to severe TS patients. CONCLUSIONS: These data support our hypothesis that at least some TS patients may have a decreased capacity to inhibit autoreactive lymphocytes through a deficit in T reg cells. Interactions of host T cell immunity and microbial factors may also contribute to the pathogenesis of TS.


Subject(s)
Immune Tolerance/physiology , T-Lymphocytes/physiology , Tourette Syndrome/immunology , Adolescent , Age of Onset , Antigens, CD/immunology , Antigens, CD/metabolism , Antigens, Differentiation, T-Lymphocyte/immunology , Antigens, Differentiation, T-Lymphocyte/metabolism , Autoantigens/analysis , Autoantigens/immunology , Blood Cell Count , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/immunology , Child , Data Interpretation, Statistical , Female , Flow Cytometry , Humans , Interleukin-2 Receptor alpha Subunit/immunology , Interleukin-2 Receptor alpha Subunit/metabolism , Lectins, C-Type , Lymphocyte Count , Male , Streptococcal Infections/immunology , Tic Disorders/immunology , Tourette Syndrome/psychology
17.
Neurochem Res ; 31(11): 1305-16, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17053972

ABSTRACT

Peroxisome proliferator-activated receptors (PPARs) play roles in neural cells by regulating energy balance, cell proliferation and anti-oxidant responses although the molecular mechanisms underlying such roles are unclear. Chronic exposure to excess manganese (Mn) leads to neurotoxicity, although Mn-induced neurotoxic mechanisms have not been fully elucidated. We hypothesized Mn neurotoxicity differentially alters the expression of PPARs. We investigated the effects of manganese chloride treatment (0.01-4 mM) on protein expression of PPAR isoforms (alpha, beta, and gamma) in human astrocytoma (U87) and neuroblastoma (SK-N-SH) cells. The two cell types expressed the 3 PPAR isoforms differentially: their expression of the PPARs was altered by Mn-treatment. Furthermore, nuclear and cytosolic fractions derived from the 2 cell types, with and without Mn-treatment, exhibited marked differences in the protein content of PPARs. Our results constitute the first demonstration that the PPAR signaling pathway may assume pathophysiological importance in Mn neurotoxicity.


Subject(s)
Astrocytoma/metabolism , Brain Neoplasms/metabolism , Manganese Poisoning/metabolism , Neuroblastoma/metabolism , Peroxisome Proliferator-Activated Receptors/biosynthesis , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytosol/drug effects , Cytosol/metabolism , Humans , Immunoblotting , Manganese Poisoning/pathology , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , PPAR alpha/metabolism , PPAR gamma/metabolism , PPAR-beta/metabolism , Signal Transduction/drug effects
18.
Biol Psychiatry ; 57(6): 667-73, 2005 Mar 15.
Article in English | MEDLINE | ID: mdl-15780855

ABSTRACT

BACKGROUND: The hypothesis that common infections can modulate the onset and course of tic disorders and early-onset obsessive-compulsive disorder (OCD) in pediatric populations is longstanding. To date, most investigations have focused on the hypothesis of molecular mimicry and humoral immune responses. This study was carried out to investigate whether cytokines associated with the innate immune response or T cell activation were altered under baseline conditions and during periods of symptom exacerbation. METHODS: Forty-six patients with Tourette's syndrome and/or early-onset OCD, aged 7-17 years, and 31 age-matched control subjects participated in a prospective longitudinal study. Ratings of clinical severity and serum were collected at regular intervals, and serum concentrations of 10 cytokines were measured repeatedly. RESULTS: Interleukin-12 and tumor necrosis factor alpha concentrations at baseline were elevated in patients compared with control subjects. Both of these markers were further increased during periods of symptom exacerbation. CONCLUSIONS: These findings suggest that symptom exacerbations are associated with an inflammatory process propagated by systemic and local cytokine synthesis that might involve the central nervous system. We conclude that, in the future, longitudinal studies of children with neuropsychiatric disorders should examine the involvement of innate and T cell immunity.


Subject(s)
Interleukin-12/blood , Tourette Syndrome/blood , Tumor Necrosis Factor-alpha/metabolism , Adolescent , Case-Control Studies , Child , Cytokines/blood , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Longitudinal Studies , Male , Prospective Studies
19.
Immunology ; 113(2): 234-45, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15379984

ABSTRACT

Contact skin immunization of mice with reactive hapten antigen and subsequent airway challenge with the same hapten induces immediate airflow obstruction and subsequent airway hyper-reactivity (AHR) to methacholine challenge, which is dependent on B cells but not on T cells. This responsiveness to airway challenge with antigen is elicited as early as 1 day postimmunization and can be adoptively transferred to naïve recipients via 1-day immune cells. Responses are absent in 1-day immune B-cell-deficient JH(-/-) mice and B-1 B-cell-deficient xid male mice, as well as in recipients of 1-day immune cells depleted of cells with the B-1 cell phenotype (CD19(+) B220(+) CD5(+)). As B-1 cells produce immunoglobulin M (IgM), we sought and found significantly increased numbers of anti-hapten IgM-producing cells in the spleen and lymph nodes of 1-day immune wild-type mice, but not in xid mice. Then, we passively immunized naive mice with anti-hapten IgM monoclonal antibody and, following airway hapten challenge of the recipients, we showed both immediate airflow obstruction and AHR. In addition, AHR was absent in complement C5 and C5a receptor-deficient mice. In summary, this study of the very early elicited phase of a hapten asthma model suggests, for the first time, a role of B-1 cells in producing IgM to activate complement to rapidly mediate asthma airway reactivity only 1 day after immunization.


Subject(s)
Asthma/immunology , B-Lymphocytes/immunology , Bronchial Hyperreactivity/immunology , Complement C5a/immunology , Immunoglobulin M/immunology , Animals , Asthma/pathology , Asthma/physiopathology , Bronchial Hyperreactivity/pathology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Female , Haptens/immunology , Immunization/methods , Lung/pathology , Male , Methacholine Chloride/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Respiratory Function Tests , Respiratory System
20.
Immunology ; 111(3): 306-17, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15009431

ABSTRACT

We investigated the role of T helper (Th)1- and Th2-type cytokines in delayed-type hypersensitivity to soluble protein antigens elicited early postimmunization. Mice were sensitized by intradermal injection without adjuvants, or subcutaneously with complete Freund's adjuvant, and subsequently ear challenged intradermally. As soon as day 3, antigen-specific eosinophil-rich responses were elicited in wild-type mice, but not in T-cell receptor-alpha-/- mice without adjuvant. Draining lymph node T cells stimulated with antigen secreted interleukin (IL)-4, IL-5 and interferon-gamma (IFN-gamma). IFN-gamma-dependent specific immunoglobulin G (IgG)2a and IL-4-dependent IgG1 were also generated. Delayed-type hypersensitivity ear swelling and local eosinophil recruitment were decreased in IL-5-/-, IL-4-/- and signal transducer and activator of transcription-6 (STAT-6)-/- mice, and with anti-IL-4 treatment of wild-type mice, suggesting Th2 mechanisms. Interestingly, responses were also decreased in IFN-gamma-/- mice, and IFN-gamma protein and the IFN-gamma-inducible CXC chemokine, IP-10, were present in 24-hr ear tissue extracts, suggesting Th1 effects. Finally, ear swelling, total histology and eosinophils were decreased in mice deficient in CXCR3, the chemokine receptor for IP-10. These results suggest that both a Th2-like (IL-5, IL-4 and STAT-6) and a Th1-like (IFN-gamma, IP-10, CXCR3) pathway contribute to eosinophil recruitment in early delayed-type hypersensitivity.


Subject(s)
Chemokines, CXC/immunology , Cytokines/immunology , Eosinophils/immunology , Hypersensitivity, Delayed/immunology , T-Lymphocytes, Helper-Inducer/immunology , Animals , Chemokine CXCL10 , Enzyme-Linked Immunosorbent Assay/methods , Epitopes/immunology , Female , Hypersensitivity, Delayed/enzymology , Interferon-gamma/immunology , Interleukin-4/immunology , Interleukin-5/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred CBA , Receptors, CXCR3 , Receptors, Chemokine/immunology , STAT6 Transcription Factor , Signal Transduction/immunology , Th1 Cells/immunology , Th2 Cells/immunology , Trans-Activators/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...